FDC
Back to Income Statement
|
FDC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,108 Cr | ₹1,943 Cr | ₹1,784 Cr | ₹1,528 Cr | ₹1,333 Cr |
What is the latest Revenue of FDC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,108 Cr |
| Mar2024 | ₹1,943 Cr |
| Mar2023 | ₹1,784 Cr |
| Mar2022 | ₹1,528 Cr |
| Mar2021 | ₹1,333 Cr |
How is Revenue of FDC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,108 Cr | 8.50 | |
| Mar2024 | ₹1,943 Cr | 8.92 | |
| Mar2023 | ₹1,784 Cr | 16.74 | |
| Mar2022 | ₹1,528 Cr | 14.61 | |
| Mar2021 | ₹1,333 Cr | - | |
Compare Revenue of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,810.3 Cr | -3.6% | -5.4% | -9.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -3.6% |
-5.4% |
-9.3% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses